Lysol teams up with NFL legend Jerry Rice
Lysol has enlisted National Football League hall-of-famer Jerry Rice as the disinfectant and household cleaning brand’s first Healthy Habits Coach.
CDR
Meijer clears flu shot myths
Meijer Inc. expects to provide 30% more flu shots this season versus a year ago but notes that many families aren’t looking to get vaccinated as soon as they should. The supercenter retailer said Tuesday that the back-to-school season is the best time for flu immunizations to help limit the spread
Dollar General ups offer to buy Family Dollar
Dollar General Corp. has raised its bid to acquire Family Dollar Stores, sending its rival a new acquisition proposal valued at about $9.1 billion. In making its new offer on Tuesday, Dollar General also said it would be willing to divest up to 1,500 stores — more than twice as many as
Hershey brand update includes new logo
The Hershey Co. has updated its corporate brand and unveiled a new company logo. The new Hershey Co. corporate logo.
Energizer unveils exec teams following household, personal care split
Energizer Holdings Inc. has announced the expected executive leadership teams of the Personal Care and Household Products businesses following the planned separation of Energizer next summer. Energizer said late Thursday that the spinoff of the two business is slated to take place by July 1, 2015.
CCA divests Mega-T weight-loss brand
CCA Industries Inc. has sold its weight-loss business, marketed under the Mega-T brand, to a group formed by Casla Partners Capital Fund I, LP. Financial terms of the transaction, announced late Thursday, weren’t disclosed.
Despite shorter season, holiday sales rise
Holiday sales edged up at drug chains in 2013 despite the impact of a shorter shopping season. The late Thanksgiving this year — falling on Nov. 28 versus Nov. 22 in 2012 — cut the holiday shopping season to 26 days from 32 days a year earlier. Still, the chain drug sector
SoloHealth Station tops 40 million consumer engagements
SoloHealth’s SoloHealth Station health and wellness kiosk has exceeded the 40 million mark in consumer engagements, averaging almost 130,000 users per day. The company said Friday that its health station is drawing about 10 million users per quarter and projecting 40 million annually.
NACDS calls for improved patient experience with ACA insurance rollout
The National Association of Chain Drug Stores has expressed its support for a pharmacy-specific recommendation by the Centers for Medicare & Medicaid Services (CMS) that would improve the Jan. 1 rollout of exchange-based insurance coverage.
CVS Caremark to resume Silverscript Part D enrollment
The Centers for Medicare & Medicaid Services (CMS) lifted sanctions imposed against CVS Caremark Corp.’s SilverScript Medicare Part D prescription drug plan (PDP).
Kao USA exec promoted to vice president of sales
John Sullivan has been named vice president of sales at Kao USA. The beauty care and personal care company said Friday that Sullivan, who will start in the new post Jan. 1, replaces Paul Nunnari, who has been appointed as president of Kao Canada.
Walgreens starts off strong in new fiscal year
Walgreen Co. reported a surge in earnings and robust sales gains for its fiscal 2014 first quarter. Walgreens said that it filled a record number of prescriptions during the fiscal 2014 first quarter. Walgreens said Friday that for the first quarter ended Nov. 30.
Forest Labs releases depression drug Fetzima
Forest Laboratories Inc. has rolled out Fetzima extended-release capsules, a medication for major depressive disorder (MDD), to U.S. pharmacies.
Pantene kicks off global #ShineStrong campaign
In the wake of its recent success of the thought-provoking "Be Strong and Shine" viral video, which depicts gender labels in the workplace, Pantene is launching the global #ShineStrong campaign.
Bristol-Myers to sell AstraZeneca its stake in diabetes venture
Bristol-Myers Squibb Co. has agreed to sell its global diabetes business that was part of its collaboration with AstraZeneca. The company said Thursday that under the agreement, it will receive an upfront payment of $2.
GSK, Theravance inhaler for COPD cleared by FDA
GlaxoSmithKline plc and Theravance Inc.